KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Non-Current Debt: 2009-2015

Historic Non-Current Debt for Novavax (NVAX) over the last 6 years, with Sep 2015 value amounting to $45,000.

  • Novavax's Non-Current Debt was N/A to $45,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $45,000, marking a year-over-year change of. This contributed to the annual value of $395,000 for FY2014, which is 60.66% down from last year.
  • Novavax's Non-Current Debt amounted to $45,000 in Q3 2015, which was down 69.80% from $149,000 recorded in Q2 2015.
  • Novavax's 5-year Non-Current Debt high stood at $1.7 million for Q2 2013, and its period low was $45,000 during Q3 2015.
  • Over the past 3 years, Novavax's median Non-Current Debt value was $861,000 (recorded in 2014), while the average stood at $811,333.
  • As far as peak fluctuations go, Novavax's Non-Current Debt soared by 313.25% in 2013, and later plummeted by 70.73% in 2015.
  • Novavax's Non-Current Debt (Quarterly) stood at $300,000 in 2011, then surged by 151.00% to $753,000 in 2012, then soared by 33.33% to $1.0 million in 2013, then plummeted by 60.66% to $395,000 in 2014, then crashed by 70.73% to $45,000 in 2015.
  • Its Non-Current Debt stands at $45,000 for Q3 2015, versus $149,000 for Q2 2015 and $252,000 for Q1 2015.